Serna-Higuita, Lina Maria, Harrison, Simone L., Buttner, Petra, Glasby, Margaret, Raasch, Beverly A., Iftner, Angelika, Garbe, Claus, Martus, Peter, and Iftner, Thomas (2019) Modifiable risk-factors for keratinocyte cancers in Australia: a case-control study. Acta Dermato-Venereologica, 99 (4). pp. 404-411.

Zelba, Henning, Weide, Benjamin, Martens, Alexander, Derhovanessian, Evelyna, Bailur, Jithendra Kini, Kyzirakos, Christina, Pflugfelder, Annette, Eigentler, Thomas K., Di Giacomo, Anna Maria, Maio, Michele, Aarntzen, Erik H.J.G., de Vries, Jolanda, Sucker, Antje, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2014) Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma. Clinical Cancer Research, 20 (16). pp. 4390-4399.

Meckbach, Diana, Keim, Ulrike, Richter, Sabina, Leiter, Ulrike, Eigentler, Thomas K., Bauer, Jürgen, Pflugfelder, Annette, Büttner, Petra, Garbe, Claus, and Weide, Benjamin (2014) BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy. PLoS ONE, 9 (2). e89218. pp. 1-7.

Weide, Benjamin, Martens, Alexander, Zelba, Henning, Stutz, Christina, Derhovanessian, Evelyna, Di Giacomo, Anna Maria, Maio, Michele, Sucker, Antje, Schilling, Bastian, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2014) Myeloid-rerived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1-or Melan-A-specific T cells. Clinical Cancer Research, 20 (6). pp. 1601-1609.

Meckbach, Diana, Bauer, Jürgen, Pflugfelder, Annette, Meier, Friedegund, Busch, Christian, Eigentler, Thomas K., Capper, David, Mittelbronn, Michel, Von Deimling, Andreas, Perner, Sven, Ikenberg, Kristian, Hantschke, Markus, Büttner, Petra, Garbe, Claus, and Weide, Benjamin (2014) Survival according to BRAF-V600 tumor mutations - An analysis of 437 patients with primary melanoma. PLoS ONE, 9 (1). e86194. pp. 1-10.

Weide, Benjamin, Richter, Sabina, Büttner, Petra, Leiter, Ulrike, Forschner, Andrea, Bauer, Jürgen, Held, Laura, Eigentler, Thomas Kurt, Meier, Friedegund, and Garbe, Claus (2013) Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. PLoS ONE, 8 (11). e81624. pp. 1-7.

Weide, Benjamin, Faller, Christine, Elsässer, Margrit, Büttner, Petra, Pflugfelder, Annette, Leiter, Ulrike, Eigentler, Thomas Kurt, Bauer, Jürgen, Meier, Friedegund, and Garbe, Claus (2013) Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour. PLoS ONE, 8 (6). e66953. pp. 1-7.

Weide, Benjamin, Faller, Christine, Büttner, Petra, Pflugfelder, Annette, Leiter, Ulrike, Eigentler, Thomas Kurt, Bauer, Jürgen, Forschner, Andrea, Meier, Friedegund, and Garbe, Claus (2013) Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis. PLoS ONE, 8 (4). e63137. pp. 1-6.

Leiter, Ulrike, Buettner, Petra G., Eigentler, Thomas K., Bröcker, Eva B., Voit, Christiane, Gollnick, Harald, Marsch, Wolfgang, Wollina, Uwe, Meier, Friedegund, and Garbe, Claus (2012) Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. Journal of the American Academy of Dermatology, 66 (1). pp. 37-45.

Weide, Benjamin, Zelba, Henning, Derhovanessian, Evelyna, Pflugfelder, Annette, Eigentler, Thomas K., Giacomo, Anna Maria Di, Maio, Michele, Aarntzen, Erik H.J.G., de Vries, I. Jolanda, Sucker, Antje, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2012) Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis. Journal of Clinical Oncology, 30 (15). pp. 1835-1841.

Elsaeßer, Otmar, Leiter, Ulrike, Buettner, Petra G., Eigentler, Thomas K., Meier, Friedegund, Weide, Benjamin, Metzler, Gisela, Breuninger, Helmut, and Garbe, Claus (2012) Prognosis of sentinel node staged patients with primary cutaneous melanoma. PLoS ONE, 7 (1). e29791. pp. 1-8.

Weide, B., Elsässer, M., Büttner, P., Pflugfelder, A., Leiter, U., Eigentler, T.K., Bauer, J., Witte, M., Meier, F., and Garbe, C. (2012) Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. British Journal of Cancer (BJC), 107 (3). pp. 422-428.

Leiter, Ulrike, and Garbe, Claus (2011) In Reply: sentinel lymph node biopsy in melanoma. Annals of Surgical Oncology, 18 (2). pp. 598-599.

Pfeil, Anne F., Leiter, Ulrike, Buettner, Petra G., Eigentler, Thomas K., Weide, Benjamin, Meier, Friedegund, and Garbe, Claus (2011) Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009. Melanoma Research, 21 (3). pp. 228-234.

Leiter, U., Weichenthal, M., Hauschild, A., Schadendorf, D., Buettner, P., and Garbe, C. (2011) Prospective comparative study of two rehabilitation schemes in 2354 patients with malignant melanoma. Journal der Deutschen Dermatologischen Gesellschaft, 9 (Supplement S1). p. 139.

Mervic, Liljana, Leiter, Ulrike, Meier, Friedegund, Eigentler, Thomas, Forschner, Andrea, Metzler, Gisela, Bartenjev, Igor, Büttner, Petra, and Garbe, Claus (2011) Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients. Melanoma Research, 21 (3). pp. 244-252.

Leiter, Ulrike, Buettner, Petra G., Eigentler, Thomas K., Forschner, Andrea, Meier, Friedegund, and Garbe, Claus (2010) Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Research, 20 (3). pp. 240-246.

Leiter, Ulrike, Buettner, Petra, Bohnenberger, Katrin, Eigentler, Thomas, Meier, Friedegund, Moehrle, Matthias, Breuninger, Helmut, and Garbe, Claus (2010) Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Annals of Surgical Oncology, 17 (1). pp. 129-137.

Iftner, Thomas, Iftner, Angelika, Buttner, Petra G., Harrison, Simone L., Glasby, Margaret, Raasch, Beverly A., and Garbe, Claus (2009) Human papillomavirus is basal cell carcinoma - a pilot study. Journal of Rural and Tropical Public Health, 8. pp. 42-44.

Schwager, Silke S., Leiter, Ulrike, Buttner, Petra G., Voit, Christiane, Marsch, Wolfgang, Gutzmar, Ralf, Naeher, Helmut, Gollnick, Harald, Broecker, Eva, and Garbe, Claus (2008) Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Melanoma Research, 18 (2). pp. 112-119.

Raasch, B.A., Buttner, P.G., and Garbe, C. (2006) Basal cell carcinoma: histological classification and body-site distribution. British Journal of Clinical Pharmacology, 155 (2). pp. 401-407.

Bauer, Jurgen, Buttner, Petra, Wiecker, Tine Sander, Luther, Heike, and Garbe, Claus (2005) An interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. International Journal of Cancer, 116 (5). pp. 755-761.

Bauer, Jurgen, Buttner, Petra, Wiecker, Tine Sander, Luther, Heike, and Garbe, Claus (2005) Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1232 young German children. International Journal of Cancer, 115 (1). pp. 121-126.

Bauer, Juergen, Buttner, Petra, Sander-Wiecker, Tine, Luther, Heike, and Garbe, Claus (2005) Effect of sunscreen and clothing on the number of melanocytic nevi in 1812 German children attending day care. American Journal of Epidemiology, 161 (7). pp. 620-627.

Buttner, Petra G., Leiter, Ulrike, Eigentier, Thomas K., and Garbe, Claus (2005) Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer, 103 (3). pp. 616-624.

Eigentler, Thomas K., Buttner, Petra G., Leiter, Ulrike, and Garbe, Claus (2004) Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on cancer staging system: an analysis of the German Central Malignant Melanoma Registry. Journal of Clinical Oncology, 22 (21). pp. 4376-4383.

Leiter, Ulrike, Buttner, Petra G., Eigentler, Thomas K., and Garbe, Claus (2004) Prognostic factors of thin cutaneous melanoma: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Journal of Clinical Oncology, 22 (18). pp. 3660-3667.

Bauer, Jürgen, Büttner, Petra, Luther, Heike, Wiecker, Tine Sander, Möhrle, Matthias, and Garbe, Claus (2004) Blue light phototherapy of neonatal jaundice does not increase risk for melanocytic nevus development. Archives of Dermatology, 140 (4). pp. 493-494.

Wiecker, Tine Sander, Luther, Heike, Buettner, Petra, Bauer, Jurgen, and Garbe, Claus (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood. Cancer, 97 (3). pp. 628-638.

Garbe, Claus, McLeod, G Roderick C., and Buettner, Petra G. (2000) Time trends of cutaneous melanoma in Queensland, Australia and central Europe. Cancer, 89 (6). pp. 1269-1278.

Garbe, Claus, and Buettner, Petra G. (2000) Predictors of the use of sunscreen in dermatological patients in central Europe. Preventive Medicine, 31 (2). pp. 134-139.

Buettner, Petra G., and Garbe, Claus (2000) Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. American Journal of Epidemiology, 151 (1). pp. 72-77.